Congratulations Eco! Up 77% in a nasty period in the market,well done.

No offering. Up she goes!

$13.37News...

The weekly gift continues..

https://archive.fast-edgar.com/20250428/AQ2NL22CZ22EWJY2222A2ZE2F5GCZZ22N272/exh_991.htm

Good morning! ~Rig

NIO Mitch, Motley Fool Battery Swapping.

The “movers and the fakers” like Motley Fool are finally admitting Battery Swapping is the best invention since sliced bread. This is a good sign Wallstreet is changing their spin narrative on NIO.

https://m.youtube.com/watch?v

Updating devices that were never needed and inferior will not make them more desirable Alexoops. 
But good try. 
Good thing Steve has 4.5 billion more share to sell before the next reverse split. 

🚨 *SPAIN HIT BY MAJOR BLACKOUT, GOVERNMENT SAYS

Scholar Rock appoints David Hallal as CEO, adds three members to leadership
Scholar Rock has appointed David Hallal as CEO succeeding Jay Backstrom. David Hallal has served as Chairman of the Board at Scholar Rock since 2017 and just prior to that spent more than a decade as CEO, COO, and CCO

If the investors just read your posts they would never know about the massive weekly dilution. Why do you never address where all the money goes and how wasteful Steve is? It's a share selling scheme. 

🫠 .. sounds like it will be close..
.. this is fun:
[yt]49-XqrqG4vo[/yt]
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176120605

BKNG
Booking Holdings price target raised to $5,580 from $5,540 at BofA
BofA raised the firm's price target on Booking Holdings to $5,580 from $5,540 and keeps a Neutral rating on the shares ahead of the company's earnings due on April 29. Following Accor's Q1 results and outlook th

TTWO
Take-Two price target raised to $250 from $210 at BofA
BofA raised the firm's price target on Take-Two Interactive to $250 from $210 and keeps a Buy rating on the shares. In the event of a macro slowdown, the firm expects Take-Two to outperform video game peers and consumer dis

****** New ******

https://annualmeeting.asgct.org/program

“Category:
Disease Models and Clinical Applications: B2 - Liver Genetic Diseases (including Hemophilia)“

“Engineering an Endoplasm

argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
https://ih.advfn.com/stock-market/NASDAQ/argenx-ARGX/stock-news/95915530/argenx-announces-positive-chmp-opinion-for-vyvgart

$500 + million / yr 5 year projected revenues.

Citi Nio: Expects Stock Price to Double $8.10

https://eletric-vehicles.com/nio/citi-adds-nio-to-30-day-positive-catalyst-watch-expects-stock-price-to-double/

The firm pointed to three key drivers: “(1) New model launches; (2) New ADAS and new chips; and (3) Cost savings

I think you have a better chance winning on a slot machine rather than a race at Dega

Up 7% today so far:-)

Zzzzzzzzz…. nothing to see here..

Couple things worth watching are two doc's by his wife Daryl Hannah

The Barn
[yt]mbmkek5j6Vs[/yt]

Coastal
[yt]aos5T2RRd_E[/yt]

Good morning CLNVERS 

IB has left the building !

100% bottom is in. Perfect time to accumulate.